Skip to main content
Log in

Effect of lonidamine on human malignant gliomas: Biochemical studies

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Lonidamine (LND) has been shown to inhibit tumor aerobic glycolysis. Its effect was evaluated on several human astrocytomas at different degrees of malignancy; a correlation was found between LDN effect on lactate production and tumor malignancy: in grade I and II astrocytomas LND stimulates lactate production, while in grade III, IV and glioblastoma multiforme lactate production is inhibited.

In an attempt to explain this different behaviour, hexokinase content and compartmentation was evaluated in astrocytomas from fresh operatory specimens and from cultured cells as well, observing a significative correlation between malignancy, hexokinase activity, percent of mitochondrially-bound hexokinase and LND effect.

The results justify from a biochemical point of view the role of LND as a ‘non-conventional’ agent in multimodality combined treatment for malignant gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Burk D, Wood M, Hunter J: On the significance of glucolysis for cancer growth, with special references to Morris rat hepatomas. J Natl Cancer Inst 38:839–863, 1967

    Google Scholar 

  2. Warburg O: The metabolism of tumors. Constable, London, 1930

    Google Scholar 

  3. Warburg O: On the origin of cancer cells. Science (Wash DC) 123:309–314, 1956

    Google Scholar 

  4. Pedersen PL: Tumor mitochondria and bioenergetics of cancer cells. Prog Exp Tumor Res 22:190–274, 1978

    Google Scholar 

  5. Wenner CE: Regulation of energy metabolism in normal and tumor tissue, in: Becker FF (ed) Cancer, a comprehensive treatise, Plenum Publ Corp, New York, 1975, vol 3, pp 389–403

    Google Scholar 

  6. Suolinna EM, Bushbaum RN, Racker E: The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res 35:1865–1872, 1975

    Google Scholar 

  7. Suolinna EM, Lang DR, Racker E: Quercetin, an artificial regulator of the high aerobic glycolysis of tumor cells. J Natl Cancer Inst 53:11515–11519, 1974

    Google Scholar 

  8. Graziani Y: Bioflavonoid regulation of ATPase and hexokinase activity in Ehrlich ascites tumor mitochondria. Biochem Biophys Acta 460:364–373, 1977

    Google Scholar 

  9. Hume DA, Weidemann MJ: Role and regulation of glucose metabolism in proliferating cells.. J Natl Cancer Inst 62:3–9, 1979

    Google Scholar 

  10. Racker E: Bioenergetics and the problem of tumor growth. Amer Sci 60:56–63, 1972

    Google Scholar 

  11. Scholnick P, Land D, Racker E: Regulatory mechanisms in carbohydrate metabolism. IX Stimulation of aerobic glycolysis by energy-linked ion transport and inhibition by dextran sulphate. J Biol Chem 248:5175–5182, 1973

    Google Scholar 

  12. Floridi A, De Martino C, Marcante ML, Apollonj-Ghetti C, Scorza-Barcellona P, Silvestrini B: Morphological and biochemical modifications of rat germ cells mitochondria induced by new antispermatogenic compounds. Exp Mol Path 35:314–331, 1981

    Google Scholar 

  13. Floridi A, Lehninger AL: Action of the antitumor and antispermatogenic agent Lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch Biochem Biophys 226:73–83, 1983

    Google Scholar 

  14. Floridi A, Paggi MG, Marcante ML, Silvestrini B, Caputo A, De Martino C: Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. J Natl Cancer Inst 66:477–479, 1981

    Google Scholar 

  15. Floridi A, Paggi MG, D'Atri S, De Martino C, Marcante ML, Silvestrini B, Caputo A: Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res 41:4661–4666, 1981

    Google Scholar 

  16. Scott DBM, Morris AL, Reiskin AB, Pakoskey AM: Carcinogenesis in the hamster cheek pouch. II Changes in enzymes of glucose-6-phosphate oxidation. Cancer Res 22:857–866, 1962

    Google Scholar 

  17. Scott DMB, Pakoskey AM, Sanford KKJ: Analysis of enzymatic activities of clones derived from variant cell lines transformed to malignant cells in tissue culture. J Natl Cancer Inst 25:1365–1369, 1960

    Google Scholar 

  18. Lange CFJ, Kohn P: Hexokinase specificity of some tumor tissue extracts. Cancer Res 21:1055–1061, 1961

    Google Scholar 

  19. Perria L, Viale GL, Ibba F, Andreussi L, Viale E: Istochimica dei tumooi endocranici. Neuropsichiatria 20:3–10, 1964

    Google Scholar 

  20. Timperley WR: Glycolysis in neuroectodermal tumours, in: Thomas DGT & Graham DI (eds) Brain Tumours: scientific basis, clinical investigation and current therapy, Butterworths, London, 1980, pp 145–167

    Google Scholar 

  21. Greco C, Candiloro A, Caputo A, Carapella CM, Giovanella B, Riccio A, Silvestrini B, Zupi G: Characterization and chemosensitivity of two human glioma derived cell lines. Proc AACR 27:98, 1986

    Google Scholar 

  22. Hohorst HJ: Determination with lactic-dehydrogenase and DPN, in: Bergmeyer HU (ed) Methods of enzymatic analysis. Acad Press Inc., New York, 1965, pp 226–270

    Google Scholar 

  23. Parry DM, Pedersen PL: Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location. J Biol Chem 258:10904–10912, 1983

    Google Scholar 

  24. Kornblith PL, Cummins CJ, Smith BH, Brooks RA, Patronas NJ, Di Chiro G: Correlation of experimental and clinical studies of metabolism by PET scanning. Prog Exp Tumor Res 27:170–178, 1984

    Google Scholar 

  25. Paggi MG, Zupi G, Fanciulli M, Del Carlo C, Giorno S, Laudonio N, Silvestrini B, Caputo A, Floridi A: Effect of lonidamine on 14C-labeled glucose by human astrocytoma cells. Exp Mol Path 47:154–165, 1987

    Google Scholar 

  26. Bustamante E, Morris HP, Pedersen PL: Hexokinase. The direct link between mitochondrial and glycolytic reaction in rapidly growing cancer cells. Adv Exp Med Biol 92:363–380, 1972

    Google Scholar 

  27. Wilson JE: Brain hexokinase. The prototype ambiquitous enzyme. Curr Thp Cell Regul 16:1–54, 1980

    Google Scholar 

  28. Purich DL, Fromm HJ, Rudolph FB: The hexokinases: kinetic, physical and regulatory properties. Adv Enzymol 39:249–326, 1973

    Google Scholar 

  29. Ballatori N, Cohen JJ: Intracellular distribution of hexokinase in the tissue zones of rat kidney. Biochem Biophys Acta 657:448–456, 1981

    Google Scholar 

  30. Bessman SP, Geiger PJ: Compartmentation of hexokinase and creatine phophokinase, cellular regulation and insulin action. Curr Top Cell Regul 16:55–86, 1980

    Google Scholar 

  31. Paggi MG, De Santis R, Floridi A, Chersi A, Tecce R, Marcante ML, Pedersen PL: Characterization of AS-30D rat hepatoma mitochondrially-bound hexokinase isozymes, in: Galeotti T, Cittadini A, Neri G, Papa S, Smets LA (eds) Cell membranes and cancer, Elsevier, Amsterdam, 1985, pp 203–208

    Google Scholar 

  32. Lusk JA, Manthorpe CM, Kao-Jen J, Wilson JE: Predominance of the cytoplasmatic form of brain hexokinase in cultured astrocytes. J Neurochem 34:1412–1420, 1980

    Google Scholar 

  33. Carapella CM, Paggi MG, Cattani F, Ciottoli GB, Floridi A, Jandolo B, Raus L, Riccio A, Caputo A: The potential role of Lonidamine in the treatment of malignant glioma. Phase II study. J Neuro-oncol, submitted.

Download references

Author information

Authors and Affiliations

Authors

Additional information

Work performed as part of CNR Research Project ‘Oncologia’, grant n. 86.00662.44 and partially supported by Associazione Italiana Ricerca sul Cancro, grant AIRC/86.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paggi, M.G., Carapella, C.M., Fanciulli, M. et al. Effect of lonidamine on human malignant gliomas: Biochemical studies. J Neuro-Oncol 6, 203–209 (1988). https://doi.org/10.1007/BF00163702

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00163702

Key words

Navigation